logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > Benzofuran-6-carboxylic Acid CAS 77095-51-3

Benzofuran-6-carboxylic Acid CAS 77095-51-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 77095-51-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
77095-51-3
Appearance ::
Yellow Solid
Molecular Formula::
C9H6O3
Molecular Weight::
162.142
EINECS NO::
N/A
MDL NO::
MFCD01006751
CAS NO::
77095-51-3
Appearance ::
Yellow Solid
Molecular Formula::
C9H6O3
Molecular Weight::
162.142
EINECS NO::
N/A
MDL NO::
MFCD01006751
Benzofuran-6-carboxylic Acid CAS 77095-51-3

Product Description:

Product Name: benzofuran-6-carboxylic acid CAS 77095-51-3

 

 

 

 

 

 

Synonyms:

6-Benzofurancarboxylic acid;

Benzofuran-6-carbonsaeure;

6-carboxy-benzofuran;

benzofuran-6-carboxylic acid;

1-Benzofuran-6-carboxylic acid;

2,3-dichloro-1-propanol-D5;

 

 

 

 

 

Chemical & Physical Properties:

Appearance : Yellow solid.

Assay : ≥98.0%

Density:1.364g/cm3

Boiling Point:325.559℃ at 760 mmHg

Flash Point:150.693℃

Refractive Index:1.649

 

 

 

 

 

Lifitegrast is an antagonist of leukocyte functional antigen 1, which is used to treat dry eye. Lifetegras can bind to leukocyte functional antigen-1 (LFA-1) and prevent the binding of LFA-1 to its homologous ligand intercellular adhesion molecule-1 (ICAM-1). The overexpression of ICAM-1 in cornea and conjunctiva of patients with dry eye disease. The combination of lfachemic Book-1 and ICAM-1 promotes the formation of immune synapses, which leads to the activation of T cells and their migration to target tissues. In vitro studies showed that lifegrant could inhibit the adhesion of T cells to ICAM-1 and the secretion of inflammatory cytokines in human peripheral blood monocytes. The exact mechanism of lifegras in the treatment of dry eye remains unclear.

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.